Clément Jacquemin
Research Subjects
Clément Jacquemin has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Julien Seneschal
Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint‐André, ImmunoConcept, CNRS UMR 5164 Bordeaux University Bordeaux France
3 shared publications - Katia Boniface
University of Bordeaux, CNRS, Immuno ConcEpT, UMR 5164, Bordeaux, France
3 shared publications A. Taieb
INSERM U1035, Bordeaux, France
2 shared publications- Alain Taïeb
INSERM U1312 University of Bordeaux Bordeaux France
2 shared publications - Christina Martins
Department of Dermatology, Brigham and Women’s Hospital, Boston, USA
2 shared publications - Jean-Etienne Castelain
Department of Spinal Surgery Unit, Hôpital Privé Francheville, 24000 Périgueux, France
2 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7409
Anterior Lumbar Interbody Fusion Versus Total Disc Replacement with a Viscoelastic Prosthesis for Single-Level Lumbar Degenerative Disc Disease in Young Adults: A Comparative Retrospective Cohort Study
Background/Objectives: The optimal surgical approach for patients with lumbar degenerative disc disease (DDD) remains a subject of ongoing debate, particularly when comparing anterior lumbar interbody fusion (ALIF) and total disc replacement (TDR). The primary objective of this study was to compare short-term outcomes between these two surgical approaches in terms of clinical efficacy, patient satisfaction, and safety profile. The secondary objective was to evaluate patient-specific variables associated with postoperative improvement in order to identify potential factors that may guide a personalized surgical strategy. Methods: This retrospective, single-center observational study included 87 patients who underwent single-level lumbar surgery using either an ALIF (n = 38) or TDR (n = 49) approach between January 2021 and May 2025. Eligible patients were younger than 45 years and had complete preoperative, intraoperative, and 1-year follow-up data. Demographic, clinical, preoperative, and intraoperative variables, as well as patient satisfaction and quality-of-life improvement, were collected, analyzed, and compared between groups. The primary between-group analysis used analysis of covariance (ANCOVA) with adjustment for baseline outcome values and prespecified confounders (age, sex, body mass index, smoking status, ASA class). Longitudinal effects were assessed using a linear model with treatment × time interaction and cluster-robust standard errors. A formal smoking × surgical-strategy interaction was tested in a multivariable regression on 12-month Oswestry Disability Index (ODI) change. Reporting followed the STROBE guidelines for observational studies. Results: Both groups showed substantial within-group improvement at all follow-up time points (all p < 0.05 except ALIF leg pain at 6 months; paired Wilcoxon test). Baseline-adjusted between-group comparisons (ANCOVA) showed a numerically modest early difference favoring TDR for Visual Analogue Score (VAS) low-back pain at 3 and 6 months (adjusted Δ = −1.46, 95% CI −2.63 to −0.30, p = 0.016 at 3 months; −1.35, 95% CI −2.63 to −0.07, p = 0.043 at 6 months), below the minimum clinically important difference of 2 points though neither survived Holm–Bonferroni correction for multiple comparisons. The formal treatment × time interaction test was not significant for any outcome (ODI p = 0.39; VAS back p = 0.29; VAS leg p = 0.06. Overall, 92% of patients in the ALIF group and 86% of patients in the TDR group reported being satisfied or very satisfied, and 60–72% of patients returned to work. Radiographic analysis in the TDR group showed maintained segmental mobility, with median range of motion of 4.0° (IQR 2.0–8.0°) overall (median 6.0°, IQR 4.0–8.5° at L4–L5; 3.0°, IQR 2.0–6.0° at L5–S1). A multivariable regression model on 12-month ODI change, adjusted for age, sex, BMI, ASA class, and baseline ODI, showed a highly significant smoking-burden × surgical-strategy interaction (dose–response smoker code × TDR coefficient = −9.47, 95% CI −15.6 to −3.3, p = 0.004): higher preoperative smoking burden was associated with reduced ODI improvement specifically in the TDR group (Spearman r = −0.41, p = 0.004) but not the ALIF group (Spearman r = +0.17, p = 0.32). Conclusions: This cohort study suggests that both ALIF and TDR were associated with substantial clinical improvement and high patient satisfaction at 1 year postoperatively; because treatment selection was not randomized, these findings should not be interpreted as evidence of comparative effectiveness. A modest early difference favoring TDR was observed for VAS low-back pain (below the minimum clinically important difference); no statistically significant between-group differences were demonstrated for any outcome after correction for multiple comparisons. The observed associations between 1-year ODI improvement and patient-specific variables require confirmation in larger independent cohorts. The finding of a significant smoking-burden × surgical-strategy interaction is an exploratory and hypothesis-generating and, if confirmed in prospective cohorts, may inform preoperative optimization strategies for TDR candidates.
- 24 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7409
Open AccessAnterior Lumbar Interbody Fusion Versus Total Disc Replacement with a Viscoelastic Prosthesis for Single-Level Lumbar Degenerative Disc Disease in Young Adults: A Comparative Retrospective Cohort Study
Background/Objectives: The optimal surgical approach for patients with lumbar degenerative disc disease (DDD) remains a subject of ongoing debate, particularly when comparing anterior lumbar interbody fusion (ALIF) and total disc replacement (TDR). The primary objective of this study was to compare short-term outcomes between these two surgical approaches in terms of clinical efficacy, patient satisfaction, and safety profile. The secondary objective was to evaluate patient-specific variables associated with postoperative improvement in order to identify potential factors that may guide a personalized surgical strategy. Methods: This retrospective, single-center observational study included 87 patients who underwent single-level lumbar surgery using either an ALIF (n = 38) or TDR (n = 49) approach between January 2021 and May 2025. Eligible patients were younger than 45 years and had complete preoperative, intraoperative, and 1-year follow-up data. Demographic, clinical, preoperative, and intraoperative variables, as well as patient satisfaction and quality-of-life improvement, were collected, analyzed, and compared between groups. The primary between-group analysis used analysis of covariance (ANCOVA) with adjustment for baseline outcome values and prespecified confounders (age, sex, body mass index, smoking status, ASA class). Longitudinal effects were assessed using a linear model with treatment × time interaction and cluster-robust standard errors. A formal smoking × surgical-strategy interaction was tested in a multivariable regression on 12-month Oswestry Disability Index (ODI) change. Reporting followed the STROBE guidelines for observational studies. Results: Both groups showed substantial within-group improvement at all follow-up time points (all p < 0.05 except ALIF leg pain at 6 months; paired Wilcoxon test). Baseline-adjusted between-group comparisons (ANCOVA) showed a numerically modest early difference favoring TDR for Visual Analogue Score (VAS) low-back pain at 3 and 6 months (adjusted Δ = −1.46, 95% CI −2.63 to −0.30, p = 0.016 at 3 months; −1.35, 95% CI −2.63 to −0.07, p = 0.043 at 6 months), below the minimum clinically important difference of 2 points though neither survived Holm–Bonferroni correction for multiple comparisons. The formal treatment × time interaction test was not significant for any outcome (ODI p = 0.39; VAS back p = 0.29; VAS leg p = 0.06. Overall, 92% of patients in the ALIF group and 86% of patients in the TDR group reported being satisfied or very satisfied, and 60–72% of patients returned to work. Radiographic analysis in the TDR group showed maintained segmental mobility, with median range of motion of 4.0° (IQR 2.0–8.0°) overall (median 6.0°, IQR 4.0–8.5° at L4–L5; 3.0°, IQR 2.0–6.0° at L5–S1). A multivariable regression model on 12-month ODI change, adjusted for age, sex, BMI, ASA class, and baseline ODI, showed a highly significant smoking-burden × surgical-strategy interaction (dose–response smoker code × TDR coefficient = −9.47, 95% CI −15.6 to −3.3, p = 0.004): higher preoperative smoking burden was associated with reduced ODI improvement specifically in the TDR group (Spearman r = −0.41, p = 0.004) but not the ALIF group (Spearman r = +0.17, p = 0.32). Conclusions: This cohort study suggests that both ALIF and TDR were associated with substantial clinical improvement and high patient satisfaction at 1 year postoperatively; because treatment selection was not randomized, these findings should not be interpreted as evidence of comparative effectiveness. A modest early difference favoring TDR was observed for VAS low-back pain (below the minimum clinically important difference); no statistically significant between-group differences were demonstrated for any outcome after correction for multiple comparisons. The observed associations between 1-year ODI improvement and patient-specific variables require confirmation in larger independent cohorts. The finding of a significant smoking-burden × surgical-strategy interaction is an exploratory and hypothesis-generating and, if confirmed in prospective cohorts, may inform preoperative optimization strategies for TDR candidates.
- Open Access
- 7 July 2025
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 443
Mapping gaseous ethanol in the headspace of wine glasses with an interband cascade laser sensor
- 7 July 2025
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 443
Open AccessMapping gaseous ethanol in the headspace of wine glasses with an interband cascade laser sensor
- Open Access
- 23 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 4981
Distal Junctional Failure: A Feared Complication of Multilevel Posterior Spinal Fusions
Objectives: Distal junctional failure (DJF) is less commonly described than proximal junctional failure following posterior spinal fusion, and particularly adult spinal deformity (ASD) surgery. We describe a case series of patients with DJF, taking into account sagittal spinopelvic alignment, and suggest potential risk factors in light of the current literature. Methods: We performed a single-center, retrospective review of posterior spinal fusion patients with DJF who underwent subsequent revision surgery between June 2009 and January 2019. Demographics and surgical details were collected. Radiographical measurements included the following: preoperative and postoperative sagittal and coronal alignment for each index or revision surgery. The upper-instrumented vertebra (UIV), lower instrumented vertebra (LIV), and fusion length were recorded. Results: Nineteen cases (64.7 ± 13.5 years, 12 women, seven men) were included. The mean follow-up was 4.7 ± 2.4 years. The number of instrumented levels was 6.79 ± 2.97. Among the patients, 84.2% (n = 16) presented at least one known DJF risk factor. LIV was frequently L5 (n = 10) or S1 (n = 2). Six patients had an initial circumferential fusion at the distal end. Initial DJFs were vertebral fracture distal to the fusion (n = 5), screw pull-out (n = 9), spinal stenosis (n = 4), instability (n = 4), and one early DJK. The distal mechanical complications after a first revision included screw pull-out (n = 4), screw fracture (n = 3), non-union (n = 2), and an iatrogenic spondylolisthesis. Conclusions: In this case series, insufficient sagittal balance restoration, female gender, osteoporosis, L5 or S1 LIV in long constructs were associated with DJF. Restoring spinal balance and circumferentially fusing the base of constructs represent key steps to maintain correction and prevent revisions.
- 23 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 4981
Open AccessDistal Junctional Failure: A Feared Complication of Multilevel Posterior Spinal Fusions
Objectives: Distal junctional failure (DJF) is less commonly described than proximal junctional failure following posterior spinal fusion, and particularly adult spinal deformity (ASD) surgery. We describe a case series of patients with DJF, taking into account sagittal spinopelvic alignment, and suggest potential risk factors in light of the current literature. Methods: We performed a single-center, retrospective review of posterior spinal fusion patients with DJF who underwent subsequent revision surgery between June 2009 and January 2019. Demographics and surgical details were collected. Radiographical measurements included the following: preoperative and postoperative sagittal and coronal alignment for each index or revision surgery. The upper-instrumented vertebra (UIV), lower instrumented vertebra (LIV), and fusion length were recorded. Results: Nineteen cases (64.7 ± 13.5 years, 12 women, seven men) were included. The mean follow-up was 4.7 ± 2.4 years. The number of instrumented levels was 6.79 ± 2.97. Among the patients, 84.2% (n = 16) presented at least one known DJF risk factor. LIV was frequently L5 (n = 10) or S1 (n = 2). Six patients had an initial circumferential fusion at the distal end. Initial DJFs were vertebral fracture distal to the fusion (n = 5), screw pull-out (n = 9), spinal stenosis (n = 4), instability (n = 4), and one early DJK. The distal mechanical complications after a first revision included screw pull-out (n = 4), screw fracture (n = 3), non-union (n = 2), and an iatrogenic spondylolisthesis. Conclusions: In this case series, insufficient sagittal balance restoration, female gender, osteoporosis, L5 or S1 LIV in long constructs were associated with DJF. Restoring spinal balance and circumferentially fusing the base of constructs represent key steps to maintain correction and prevent revisions.
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1194-1205.e7
Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1194-1205.e7
Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling
- 9 October 2020
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 147 (11) , A20
NKG2D : cible potentielle de la phase inflammatoire chez le patient atteint de Vitiligo
- 9 October 2020
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 147 (11) , A20
NKG2D : cible potentielle de la phase inflammatoire chez le patient atteint de Vitiligo
- 3 February 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (5) , 899-908
Phenotype and function of circulating memory T cells in human vitiligo*
Background Vitiligo is a chronic inflammatory skin disorder characterized by the loss of melanocytes. While a Th1/Tc1 skewed immune response is now well demonstrated in vitiligo, recent data suggest that the T cell component could be more complex, involving different combinatorial T cell subsets. Objectives To analyse the phenotype and function of circulating CD4+ and CD8+ memory T cell subsets in stable and active vitiligo patients, in comparison to psoriasis patients and healthy controls. Methods This is a monocentric, prospective, descriptive and exploratory study. Multiparametric flow cytometry analyses were performed to evaluate the surface expression of homing and T cell subsets markers together with intracellular cytokine production in peripheral blood mononuclear cells from 60 vitiligo patients, 25 psoriasis patients and 28 healthy donors. Results Vitiligo peripheral blood circulating effector and central memory T cells expressed similar proportion of skin homing markers. A decrease in the frequency of circulating CD4+ and CD8+ Th1/Tc1, Th17/Tc17 and Th1/Th17 or Tc1/Tc17 effector memory T cell subsets was observed in vitiligo patients in comparison to healthy donors. Similar observations were made in psoriasis. In contrast, vitiligo circulating T cells showed similar capacity of pro‐inflammatory cytokine production compared to psoriasis and healthy controls. Conclusions The decreased frequency of circulating Th1/Tc1, Th17/Tc17 and Th1/Th17‐70 Tc1/Tc17 cells suggests a possible migration of these T cell subsets into the skin of patients that could be targeted to prevent the flare of the disease.
- 3 February 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (5) , 899-908
Phenotype and function of circulating memory T cells in human vitiligo*
Background Vitiligo is a chronic inflammatory skin disorder characterized by the loss of melanocytes. While a Th1/Tc1 skewed immune response is now well demonstrated in vitiligo, recent data suggest that the T cell component could be more complex, involving different combinatorial T cell subsets. Objectives To analyse the phenotype and function of circulating CD4+ and CD8+ memory T cell subsets in stable and active vitiligo patients, in comparison to psoriasis patients and healthy controls. Methods This is a monocentric, prospective, descriptive and exploratory study. Multiparametric flow cytometry analyses were performed to evaluate the surface expression of homing and T cell subsets markers together with intracellular cytokine production in peripheral blood mononuclear cells from 60 vitiligo patients, 25 psoriasis patients and 28 healthy donors. Results Vitiligo peripheral blood circulating effector and central memory T cells expressed similar proportion of skin homing markers. A decrease in the frequency of circulating CD4+ and CD8+ Th1/Tc1, Th17/Tc17 and Th1/Th17 or Tc1/Tc17 effector memory T cell subsets was observed in vitiligo patients in comparison to healthy donors. Similar observations were made in psoriasis. In contrast, vitiligo circulating T cells showed similar capacity of pro‐inflammatory cytokine production compared to psoriasis and healthy controls. Conclusions The decreased frequency of circulating Th1/Tc1, Th17/Tc17 and Th1/Th17‐70 Tc1/Tc17 cells suggests a possible migration of these T cell subsets into the skin of patients that could be targeted to prevent the flare of the disease.
- 15 December 2018
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 32 (4) , 588-592
Imbalance of peripheral follicular helper T lymphocyte subsets in active vitiligo
Vitiligo is an autoimmune disease characterized by the presence of several autoantibodies, some of which are directed against melanocyte components and have been shown to be associated with the progression of the disease. However, the mechanism involved in the production of autoantibodies remains unclear. Follicular helper CD4+ T cells (TFH) are specialized in B‐cell activation and antibody production, especially the TFH cell subsets type 2 and type 17. To date, TFH cell subsets have not been studied in human vitiligo. This study in 44 vitiligo patients and 19 healthy controls showed an increase in circulating TFH cells associated with disease clinical progression. A more precise analysis of TFH cell phenotype demonstrated that vitiligo is characterized by populations of peripheral TFH cells responsible for helping B‐cell function, such as TFH type 2 and type 17 which produce Th2‐ and TH17‐related cytokines, respectively. These findings suggest a new mechanism involving TFH cell subsets in the pathogenesis of human vitiligo and leading to the production of autoantibodies and disease.
- 15 December 2018
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 32 (4) , 588-592
Imbalance of peripheral follicular helper T lymphocyte subsets in active vitiligo
Vitiligo is an autoimmune disease characterized by the presence of several autoantibodies, some of which are directed against melanocyte components and have been shown to be associated with the progression of the disease. However, the mechanism involved in the production of autoantibodies remains unclear. Follicular helper CD4+ T cells (TFH) are specialized in B‐cell activation and antibody production, especially the TFH cell subsets type 2 and type 17. To date, TFH cell subsets have not been studied in human vitiligo. This study in 44 vitiligo patients and 19 healthy controls showed an increase in circulating TFH cells associated with disease clinical progression. A more precise analysis of TFH cell phenotype demonstrated that vitiligo is characterized by populations of peripheral TFH cells responsible for helping B‐cell function, such as TFH type 2 and type 17 which produce Th2‐ and TH17‐related cytokines, respectively. These findings suggest a new mechanism involving TFH cell subsets in the pathogenesis of human vitiligo and leading to the production of autoantibodies and disease.